packageIdursulfase

idursulfase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Idursulfase is an enzyme replacement therapy used to treat mucopolysaccharidosis II (Hunter syndrome). It is authorised in the European Union and used as an approved medicine for this rare condition.

Summary written by glm-5.3-flash from Wikidata Q415801 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:idursulfase
ATC codes:A16AB09
DrugBank:DB01271
Wikidata:Q415801
molar mass:76000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown